22 Background 23 Low-grade systemic inflammation is a predictor of recurrent cardiac events in patients with coronary 24 artery disease (CAD). Plasma proteins such as matrix metalloproteinase (MMP)-9 and 25 myeloperoxidase (MPO) have been shown to reflect basal as well as stress-induced inflammation in 26 CAD. Measurements of MMP-9 and MPO in saliva might pose several advantages. Therefore, we 27 investigated whether salivary levels of MMP-9 and MPO corresponded to plasma levels in patients 28 with CAD, both at rest and after acute physical exercise. 29 Methods 30 An acute bout of physical exercise on a bicycle ergometer was used as a model for stress-induced 31 inflammation. Twenty-three CAD patients performed the test on two occasions 3-6 months apart. 32 Whole unstimulated saliva was collected before, directly after and 30 min after exercise while plasma 33 was collected before and after 30 min. MMP-9 and MPO in saliva and plasma were determined by 34 Luminex. 35 Results 36 MMP-9 and MPO levels were 2-to 4-fold higher in saliva than in plasma. Within the saliva 37 compartment, and also to a great extent within the plasma compartments, MMP-9 and MPO showed 38 strong intercorrelations at all time points. However, there were no (or weak) correlations between 39 salivary and plasma MMP-9 and none between salivary and plasma MPO. 40 Conclusion 41 We conclude that salivary diagnostics cannot be used to assess systemic levels of MMP-9 and MPO in 42 CAD patients, neither at rest nor after acute physical exercise. 43 44 Key words 45 Coronary artery disease; inflammation; matrix metalloproteinase-9; myeloperoxidase; saliva 46 3 47 Introduction 48 49 Inflammation is an important component of atherosclerosis, from the formation of atherosclerotic 50 plaques to plaque destabilization eventually leading to plaque rupture and atherothrombotic events, 51 such as myocardial infarction [1]. Systemic levels of inflammatory markers can be useful to assess 52 cardiovascular risk and monitor disease activity and over the years, great efforts have been made to 53 identify relevant and easily available markers. The predictive value of markers like C-reactive protein 54 (CRP) and interleukin (IL)-6 in determining the risk of myocardial infarction is well-documented [2].
183 Salivary levels of MMP-9 and MPO 184 The total protein content in saliva and protein-adjusted salivary levels of MMP-9 and MPO before (i.e. 185 basal) and after exercise stress tests on two test occasions (visit A and B) are presented in Table 2 . The 186 total protein levels in saliva increased significantly directly after exercise and returned to basal levels 187 30 min after exercise, probably reflecting a reduced salivary flow during exercise. The protein-188 adjusted levels of MMP-9 and MPO in saliva did not differ significantly between rest and exercise, 189 neither did levels differ between visit A and B. However, without adjusting for total protein content, 190 the salivary levels of MMP-9 and MPO showed significant increases after exercise as shown in Figure   191 1 a and b. In the following text, the salivary levels of MMP-9 and MPO will be referred to as protein-192 adjusted levels. 210 211 Salivary levels of total saliva and protein-adjusted levels of MMP-9 and MPO were measured before (basal), directly after an 212 acute bout of exercise (peak) and 30 min after exercise (post). Plasma levels of MMP-9 and MPO were measured before and 213 30 min after exercise, the latter adjusted for plasma loss. Exercise tests were performed on two occasions (visit A and B). 
